Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation

Hepatitis B virus (HBV) is one of the main causes of chronic liver diseases and hepatocellular carcinoma. After infection the majority of HBV-infected patients achieve immune control leading to HBV-DNA stabilization at a low level. The risk of HBV reactivation rises significantly when HBV-infected p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawłowska, Małgorzata, Flisiak, Robert, Gil, Lidia, Horban, Andrzej, Hus, Iwona, Jaroszewicz, Jerzy, Lech-Marańda, Ewa, Styczyński, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781818/
https://www.ncbi.nlm.nih.gov/pubmed/31598555
http://dx.doi.org/10.5114/ceh.2019.87631
_version_ 1783457448187658240
author Pawłowska, Małgorzata
Flisiak, Robert
Gil, Lidia
Horban, Andrzej
Hus, Iwona
Jaroszewicz, Jerzy
Lech-Marańda, Ewa
Styczyński, Jan
author_facet Pawłowska, Małgorzata
Flisiak, Robert
Gil, Lidia
Horban, Andrzej
Hus, Iwona
Jaroszewicz, Jerzy
Lech-Marańda, Ewa
Styczyński, Jan
author_sort Pawłowska, Małgorzata
collection PubMed
description Hepatitis B virus (HBV) is one of the main causes of chronic liver diseases and hepatocellular carcinoma. After infection the majority of HBV-infected patients achieve immune control leading to HBV-DNA stabilization at a low level. The risk of HBV reactivation rises significantly when HBV-infected patients receive immunosuppressive treatments. Presented recommendations provide guidelines for management of patients scheduled or undergoing therapies, which through their immunomodulatory activity contribute to the impairment of antiviral immunity, including chemotherapy, immunosuppressive treatment or biological therapy.
format Online
Article
Text
id pubmed-6781818
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-67818182019-10-09 Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation Pawłowska, Małgorzata Flisiak, Robert Gil, Lidia Horban, Andrzej Hus, Iwona Jaroszewicz, Jerzy Lech-Marańda, Ewa Styczyński, Jan Clin Exp Hepatol Review Paper Hepatitis B virus (HBV) is one of the main causes of chronic liver diseases and hepatocellular carcinoma. After infection the majority of HBV-infected patients achieve immune control leading to HBV-DNA stabilization at a low level. The risk of HBV reactivation rises significantly when HBV-infected patients receive immunosuppressive treatments. Presented recommendations provide guidelines for management of patients scheduled or undergoing therapies, which through their immunomodulatory activity contribute to the impairment of antiviral immunity, including chemotherapy, immunosuppressive treatment or biological therapy. Termedia Publishing House 2019-09-05 2019-09 /pmc/articles/PMC6781818/ /pubmed/31598555 http://dx.doi.org/10.5114/ceh.2019.87631 Text en Copyright: © 2019 Clinical and Experimental Hepatology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Review Paper
Pawłowska, Małgorzata
Flisiak, Robert
Gil, Lidia
Horban, Andrzej
Hus, Iwona
Jaroszewicz, Jerzy
Lech-Marańda, Ewa
Styczyński, Jan
Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
title Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
title_full Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
title_fullStr Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
title_full_unstemmed Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
title_short Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
title_sort prophylaxis of hepatitis b virus (hbv) infection reactivation – recommendations of the working group for prevention of hbv reactivation
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781818/
https://www.ncbi.nlm.nih.gov/pubmed/31598555
http://dx.doi.org/10.5114/ceh.2019.87631
work_keys_str_mv AT pawłowskamałgorzata prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT flisiakrobert prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT gillidia prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT horbanandrzej prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT husiwona prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT jaroszewiczjerzy prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT lechmarandaewa prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation
AT styczynskijan prophylaxisofhepatitisbvirushbvinfectionreactivationrecommendationsoftheworkinggroupforpreventionofhbvreactivation

Ejemplares similares